Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 74.82B | 74.65B | 73.50B | 70.45B | 68.45B | 67.35B |
Gross Profit | 15.98B | 15.97B | 14.99B | 11.82B | 15.58B | 16.43B |
EBITDA | 3.86B | 4.93B | 3.97B | 130.71M | 4.71B | 5.22B |
Net Income | 2.48B | 2.46B | 1.75B | -1.32B | 2.01B | 2.98B |
Balance Sheet | ||||||
Total Assets | 68.99B | 68.73B | 66.37B | 60.66B | 61.23B | 56.95B |
Cash, Cash Equivalents and Short-Term Investments | 1.57B | 1.48B | 797.03M | 463.87M | 3.53B | 2.56B |
Total Debt | 3.36B | 3.20B | 3.74B | 3.24B | 3.77B | 4.29B |
Total Liabilities | 28.14B | 27.35B | 27.11B | 26.66B | 26.30B | 24.51B |
Stockholders Equity | 40.85B | 41.39B | 39.26B | 34.00B | 34.93B | 32.44B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.87B | 302.81M | -2.46B | 2.07B | -1.84B |
Operating Cash Flow | 0.00 | 2.47B | 904.67M | -53.46M | 3.90B | 3.53B |
Investing Cash Flow | 0.00 | -680.32M | -596.29M | -2.02B | -1.92B | -5.50B |
Financing Cash Flow | 0.00 | -1.10B | 24.43M | -997.37M | -994.89M | 2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥32.06B | 16.47 | 1.15% | 3.87% | 5.01% | ||
75 Outperform | ¥28.97B | 8.03 | 2.13% | 3.36% | 29.57% | ||
74 Outperform | ¥33.45B | 14.27 | 2.73% | 10.57% | 4.52% | ||
73 Outperform | ¥33.44B | 22.81 | 1.50% | 10.43% | -0.65% | ||
68 Neutral | ¥30.82B | 12.53 | 1.83% | 1.56% | 40.56% | ||
66 Neutral | ¥43.49B | 16.50 | 3.61% | 6.28% | -36.71% | ||
65 Neutral | $26.93B | 15.26 | -4.27% | 3.16% | 1.02% | 1.89% |